| Literature DB >> 29854082 |
Neda Seyedsadjadi1,2, Jade Berg2, Ayse A Bilgin3, Ross Grant1,2,4.
Abstract
Lifestyle behaviours have been closely linked to the progressive cell damage associated with oxidative stress (OS) and the development of cardiovascular disease (CVD). Early detection of lifestyle-linked OS may therefore be useful in the early identification of prodromal disease. To test this hypothesis, this study assessed the relationship between a comprehensive redox balance lifestyle score (RBLS) and carotid intima-media thickness (CIMT), a recognized marker for CVD, and plasma biomarkers of OS. In a cross-sectional study design, 100 apparently healthy middle-aged participants were asked to complete a comprehensive lifestyle questionnaire, followed by DXA scanning, CIMT ultrasonography, and blood collection. The RBLS was composed of lifestyle components with pro- and antioxidant properties with a higher score indicative of lower oxidative activity. Multiple linear regression and logistic regression analysis were performed for statistical analysis. The RBLS was significantly associated with the risk for increased CIMT that was independent of conventional CVD risk factors (χ2(9) = 35.60, P ≤ 0.001). The adjusted model explained 42.4% of the variance in CIMT. Participants with RBLS below the median were at significantly increased risk of higher CIMT compared to participants with RBLS above the median (OR = 3.60, 95% CI: 1.19-10.88, P = 0.023). Significant associations were also observed between the RBLS, plasma total antioxidant capacity (TAC) (r(99) = 0.28, P = 0.006), hydroperoxide (HPX) (rs(99) = -0.28, P = 0.005), TAC/HPX ratio (r(98) = 0.41, P ≤ 0.001), γ-glutamyltransferase (r(97) = -0.23, P = 0.024), uric acid (r(98) = -0.20, P = 0.045), and inflammatory C-reactive protein (rs(97) = -0.25, P = 0.012) and interleukin-1β (r(97) = -0.21, P = 0.040). These findings highlight the importance of identifying the collective influence of lifestyle behaviours on OS activity and its potential to remodel the vascular endothelium.Entities:
Mesh:
Year: 2018 PMID: 29854082 PMCID: PMC5944202 DOI: 10.1155/2018/4504079
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
RBLS's point assignment scheme.
| Lifestyle component | Correlation coefficient with TAC/HPX ratio | |||
|---|---|---|---|---|
|
| ||||
| VAT fat mass (g) | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | −0.11a |
|
| ||||
| PUFA intake | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | 0.14a |
| Trans-FA intake | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | −0.05 |
| Iron intake | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | 0.10 |
| Vitamin E intake | 1 = low (1st tertile) or higher than 270 mg† | 2 = medium (2nd tertile) | 3 = high (3rd tertile) | 0.19a |
| Vitamin C intake | 1 = low (1st tertile) or higher than 500 mg† | 2 = medium (2nd tertile) | 3 = high (3rd tertile) | 0.09 |
|
| 1 = low (1st tertile) or higher than 15 mg† | 2 = medium (2nd tertile) | 3 = high (3rd tertile) | 0.29∗ |
|
| 1 = low (1st tertile) or higher than 15 mg† | 2 = medium (2nd tertile) | 3 = high (3rd tertile) | 0.19a |
| Lycopene intake | 1 = low (1st tertile) or higher than 15 mg† | 2 = medium (2nd tertile) | 3 = high (3rd tertile) | 0.04 |
| Lutein and zeaxanthin intake | 1 = low (1st tertile) or higher than 15 mg† | 2 = medium (2nd tertile) | 3 = high (3rd tertile) | 0.17 |
|
| 1 = low (1st tertile) or higher than 15 mg† | 2 = medium (2nd tertile) | 3 = high (3rd tertile) | 0.14 |
|
| ||||
| Caffeine intake | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | −0.28a∗ |
| Alcohol intake | 1 = high (>1 drink/day) | 2 = medium (1 drink/day) | 3 = low (None) | −0.14a |
| Smoking history | 1 = current smoker | 2 = previous smoker | 3 = never smoker | −0.02a |
|
| ||||
| Physical activity | 1 = sedentary/low | 2 = moderate | 3 = high | 0.17 |
| Sitting time | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | −0.21a∗ |
|
| ||||
| Depression score | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | −0.18 |
| Stress score | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | −0.09 |
| Anxiety score | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | 0.07 |
|
| ||||
| PSQI | 1 = high (3rd tertile) | 2 = medium (2nd tertile) | 3 = low (1st tertile) | −0.25∗ |
| Apnoea risk | 1 = high | 3 = low | 0.27a∗ | |
TAC: total antioxidant capacity; HPX: hydroperoxide; VAT: visceral adipose tissue; PUFA: polyunsaturated fatty acids; PSQI: Pittsburgh sleep quality index. Comparisons were made using Pearson's correlation unless otherwise stated; acomparisons were made using Spearman's correlation; ∗P < 0.05; points were calculated by multiplying the point value of each lifestyle component by the (absolute) correlation coefficient of the association between the relevant component and plasma redox balance index of TAC/HPX ratio; †the level previously linked to oxidative activity [34, 35].
Participant characteristics for individual components of the RBLS and their association with the RBLS.
| Characteristic |
| Mean ± SD | Correlation coefficient with RBLS |
|---|---|---|---|
| Lifestyle score (RBLS) | 100 | 6.69 ± 0.90 | — |
| Age | 100 | 55.98 ± 8.83 | −0.09 |
| VAT fat mass (g) | 97 | 953.12 ± 798.26 | −0.27∗ |
| PUFA intake (g/day) | 99 | 11.5 ± 5.65 | 0.12 |
| Trans FA intake (g/day) | 100 | 0.38 ± 0.31 | −0.05 |
| Iron intake (mg/day) | 99 | 12.13 ± 4.44 | −0.05 |
| Vitamin E intake (mg/day) | 99 | 7.09 ± 2.83 | 0.32∗ |
| Vitamin C intake (mg/day) | 97 | 105.54 ± 46.80 | 0.37∗ |
|
| 99 | 714.03 ± 418.73 | 0.48∗ |
|
| 99 | 3784.80 ± 1819.34 | 0.51∗ |
| Lycopene intake ( | 99 | 5143.93 ± 2639.29 | 0.04 |
| Lutein and zeaxanthin intake ( | 100 | 1011.88 ± 447.43 | 0.50∗ |
|
| 98 | 236.27 ± 172.67 | 0.38∗ |
| Caffeine intake (mg/day) | 98 | 303.06 ± 320.63 | −0.40∗a |
| Alcohol intake (g/day) | 99 | 7.57 ± 10.72 | −0.32∗a |
|
| 100 | −0.17a | |
| Current smoker | 0 | ||
| Ever smoker | 74 | ||
| Never smoker | 26 | ||
|
| 100 | 0.28∗a | |
| Sedentary/low | 20 | ||
| Moderate | 43 | ||
| High | 35 | ||
| Sitting time (min/day/week) | 99 | 399.78 ± 154.34 | −0.21∗a |
| Depression score | 98 | 2.46 ± 3.01 | −0.38∗a |
| Stress score | 99 | 4.76 ± 3.25 | −0.32∗a |
| Anxiety score | 99 | 1.56 ± 1.76 | −0.15a |
| PSQI | 97 | 4.34 ± 2.95 | −0.50∗a |
|
| 100 | 0.44∗a | |
| High risk | 20 | ||
| Low risk | 80 |
RBLS: redox balance lifestyle score; VAT: visceral adipose tissue; PUFA: polyunsaturated fatty acids; PSQI: Pittsburgh sleep quality index. Comparisons were made using Pearson's correlation unless otherwise stated; acomparisons were made using Spearman's correlation; ∗P < 0.05.
Correlation coefficients and P values for the associations between RBLS and plasma biomarkers of oxidative stress, inflammation, and other biochemical markers.
| Correlation coefficient |
| |
|---|---|---|
| Oxidative stress biomarkers | ||
| TAC (mmol/L) | 0.28 | 0.006 |
| HPX (mmol/L) | −0.28a | 0.005 |
| GGT (U/L) | −0.23 | 0.024 |
| Uric acid (mmol/L) | −0.20 | 0.045 |
| TAC/HPX | 0.41 | ≤0.001 |
|
| ||
| IL-1 | −0.21 | 0.040 |
| CRP (mg/L) | −0.25a | 0.012 |
| TNF- | −0.06 | NS |
| IL-6 (pmol/L) | −0.10a | NS |
|
| ||
| TC (mmol/L) | −0.34 | ≤0.001 |
| LDL-C (mmol/L) | −0.32 | 0.001 |
| HDL-C (mmol/L) | 0.12 | NS |
| TG (mmol/L) | −0.32a | 0.002 |
| FPG (mmol/L) | −0.30 | 0.003 |
| HbA1c (mmol/mol) | −0.23 | 0.025 |
| TG/HDL | −0.27 | 0.008 |
| TyG index | −0.40 | ≤0.001 |
RBLS: redox balance lifestyle score; TAC: total antioxidant capacity; HPX: hydroperoxide; GGT: γ-glutamyltransferase; IL-1β: interleukin-1β; CRP: C-reactive protein; TNF-α: tumour necrosis factor-α; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride; FPG: fasting plasma glucose; HbA1c: glycated hemoglobin A. Comparisons were made using Pearson's correlation unless otherwise stated; acomparisons were made using Spearman's correlation.
Figure 1Association between the redox balance lifestyle score (RBLS) and plasma redox balance indicator of the TAC/HPX ratio.
| Mean ± SD ( | |
|---|---|
| CIMT (mm) | 0.76 ± 0.18 |
| OR (95% CI) |
|
|
| |
|---|---|---|---|---|
| Model A | 4.11 (1.57–10.75) | 0.004 | 28.6% | 23.61 |
| Model B | 3.60 (1.19–10.88) | 0.023 | 42.4% | 35.60 |
Model A: adjusted for age and gender; model B: adjusted for age, gender, systolic blood pressures, diastolic blood pressures, low-density lipoprotein cholesterol, estimated glomerular filtration rate (eGFR), fasting plasma glucose, and triglyceride/high-density lipoprotein cholesterol ratio; RBLS: redox balance lifestyle score.